Ihuman Inc (IH) Quarterly Institutional 13F Update (Q2 2026)

IH ranks #10590 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

IH is a disclosed holding of Ken Griffin (Citadel Advisors LLC), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

8 institutions disclose a position in IH, but none treat it as a major bet — even Morgan Stanley, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Morgan Stanley has trimmed its IH position for two straight quarters, cutting it by $75.3K while still holding $53.2K.

IH closed its latest fiscal year with net income of $95.4M, and currently trades at a P/E of 3.4.

• Profitable — net income of $95.4M in the latest fiscal year
• Revenue declined 12.5% year over year
• Net income declined year over year, from $98.6M to $95.4M
• Generated $51.3M in positive operating cash flow
• Current ratio of 3.57x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.38x equity — within a conventional range